Data from a phase III study have linked the advanced prostate cancer drug abiraterone acetate (ZYTIGA) to delayed pain progression and functional decline in a certain subset of advanced prostate cancer patients.
The safety and oncologic benefits of transperineal vs transrectal MRI-guided prostate biopsy
March 27th 2023"These studies, taken together, offer important insight into the direction we should be heading in prostate cancer diagnosis: toward a targeted-only TP biopsy," write Tarik Benidir, MD, and Zeyad Schwen, MD.
2 Clarke Drive
Cranbury, NJ 08512